(Q33383279)

26 July 2017

title

Novel approaches in management of immune thrombocytopenia (English)

1 reference

26 July 2017

1 reference

Simon Panzer

1

1 reference

26 July 2017

publication date

1 January 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

123 Suppl 2

1 reference

26 July 2017

page(s)

S51-5

1 reference

Immune thrombocytopenic purpura

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Thrombocytopenia caused by the development of antibodies to thrombopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

New thrombopoietic growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Management of patients with refractory immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

Circulating thrombopoietin level in chronic immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970011-8

7 January 2021

10.1016/S0049-3848(09)70011-8

Identifiers

DOI

1 reference

26 July 2017

1 reference